Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (354)
SAGE documentation (33)
Scientific publications (4)
Systematic reviews (SYSVAC) (1089)
Regions
Africa (57)
Americas (187)
Eastern Mediterranean (10)
Europe (155)
South-East Asia (10)
Western Pacific (36)
Diseases
COVID-19 (1481)
Chikungunya (9)
Cholera (33)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (12)
Moderate (7)
Low (111)
Critically low (685)
Not applicable (274)
1481 results found
2020
∙
Sarah Mbaeyi, ACIP
Use of mRNA COVID-19 Vaccines: Interim Clinical Considerations
2020
∙
ACIP, Sarah Mbaeyi
Use of Pfizer-BioNTech COVID-19 Vaccine: Clinical Considerations
2020
∙
ACIP
Vaccinate with Confidence for COVID-19 Vaccines
2020
∙
Conseil Supérieur de la Santé (CSS)
Vaccination Strategy against Covid-19 in Belgium
2020
∙
Haute Autorité de Santé
Vaccination strategy against COVID-19: Anticipation of possible vaccination scenarios and preliminary recommendations on target populations
2020
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Vaccination strategy against SARS-CoV-2 - the mRNA vaccine COMIRNATY® (BNT162b2)
2020
∙
SAGE
WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination
2020
∙
Sara Oliver, ACIP
Work Group interpretation and next steps
2020
∙
Sara Oliver, ACIP
Work Group interpretations of data
Ruth Faden, Alejandro Cravioto, Joachim Hombach, David Kaslow, Sonali Kochhar, Hanna Nohynek, Annelies Wilder-Smith, Saad Omer, Matthew Crane
Who to vaccinate first? A peek at decision-making in a pandemic
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register